期刊文献+

甲状旁腺素(1-34)对卵巢切除大鼠腰椎间盘退行性变的影响 被引量:2

Effect of parathyroid hormone (1-34) on lumbar intervertebral disc degeneration in ovariectomized rats
下载PDF
导出
摘要 目的:探讨甲状旁腺素(PTH,1-34)对卵巢切除大鼠腰椎间盘退变的治疗作用及其作用机制。方法:雌性SD大鼠,随机分为假手术组、卵巢切除+生理盐水组(生理盐水组)、卵巢切除+甲状旁腺素(1-34)组(甲状旁腺组)。卵巢切除术后8周,甲状旁腺组大鼠皮下注射PTH(1-34),生理盐水组大鼠给予等剂量生理盐水。卵巢切除术后20周处死大鼠并收集标本。对第2-3腰椎椎体进行骨密度测量。对第4-5腰椎及椎间盘进行HE染色及免疫组织化学方法检测,并根据组织学评分系统对腰椎间盘的退变程度进行评分。结果:生理盐水组大鼠第2-3腰椎椎体骨密度低于甲状旁腺组及假手术组;生理盐水组大鼠第2-3腰椎椎间盘组织学评分高于甲状旁腺组及假手术组;免疫组织化学显色,甲状旁腺组与假手组大鼠椎间盘Ⅰ、Ⅱ胶原表达差异无统计学意义。结论:皮下每周注射甲状旁腺素(1-34)20μg/kg能减轻去势大鼠椎间盘的退变,使椎体骨密度增加,Ⅰ、Ⅱ胶原的表达增加。 Objective: To investigate the effects and mechanism of parathyroid hormone (1-34) on lumbar intervertebral disc in ovariectomized rats. Methods: 3-monthold female Sprague-Dawley rats were randomized into three groups. Ovariectomy was performed in OVX+NS group and OVX+PTH group, and a Sham surgery was performed in the Sham group. Four weeks after ovariectomy,the rats in OVX+PTH group and OVX+NS group received injection subcutaneously of 20 μg/kg PTH(1-34) or saline respectively every week. The lumbar vertebra were harvested 20 weeks after ovariectomy and underwent bone mineral density (BMD) measurement, hematoxylin and eosin staining and histochemistry analysis. Results: The bone mineral density of L2-3 vertebra in the OVX+NS group was significantly lower than that in the Sham group and OVX +PTH group; the histological score of L2-3 vertebra was significantly higher in OVX+NS group than that in the Sham group and OVX+PTH group. There was no significant difference in the immunostaining expressions of collagen I and collagen Ⅱ between the Sham group and OVX+PTH group. Conclusion: Subcutaneous injection of parathyroid hormone (1-34) (20 μg · kg^-1 ·weekl) for twelve weeks can delay the degenerated process of intervertehral discs in ovariectomized rats.
出处 《解剖学杂志》 CAS CSCD 北大核心 2011年第6期739-742,共4页 Chinese Journal of Anatomy
关键词 卵巢切除 椎间盘退变 免疫组织化学 甲状旁腺素 ovariectomy intervertebral disc degeneration immunohistochemistry parathyroid hormone (1-34)
  • 相关文献

参考文献18

  • 1Zhang L, Takahashi H E, Inoue J, et al. Effects of intermittent administration of low dose human PTH (1-34) on cancellous and cortical bone of lumbar vertebral bodies in adult beagles [J]. Bone, 1997,21(6):501-506.
  • 2Wang, T, Zhang L, Huang C, et al. Relationship between osteopenia and lumbar intervertebral disc degeneration in ovariectomized rats[J]. Calcif Tissue Int, 2004,5(3):205-213.
  • 3Mizrahi J, Silva M J, Keavery T M, et al. Finite-element stress analysis of the nomal and osteoporotic lumbar vertebral body [J].spine, 1993,18(14) : 2088 2096.
  • 4Courrier R. On the death of M. Albert Policard, honorary member [J]. Bull Acad Natl Med, 1972,156(8):263-264.
  • 5Pugsley L I, Selye H. The histological changes in the bone responsible for the action of parathyroid hormone on the calcium metabolism of the rat [J]. J Physiol, 1933,79(1):113-117.
  • 6Mwale F, Yao G, Ouellet J A, et al, Effect of parathyroid hormone on type X and type II collagen expression in mesenchymal stem cells from osteoarthritic patients [J]. Tissue Eng Part A, 2010,16(11) :3449-3455.
  • 7Schalin-Jiintti C, Mornet E, Lamminen A, et al. Parathyroid hor mone treatment improves pain and fracture healing in adult hy pophosphatasia [J]. J Clin Endocrinol Metab, 2010, 95 (12) 5174-5179.
  • 8Zhang L, Endo N, Yamamoto N, et al. Effects of single and con current intermittent administration of human PTH (1-34) and in cadronate on cancellous and cortical hone of femoral neck in ovari ectomized rats [J]. Tohoku J Exp Med, 1998,186(2): 131-141.
  • 9Isowa S, Shimo T, Ibaragi S, et al. PTHrP regulates angiogenesis and bone resorption via VEGF expression [J]. Antieaneer Res, 2010,30(7) :2755-2767.
  • 10Reeve J, Tregear G W, Parsons J A. Priliminary trial of low doses of human parathyroid hormone 1-34 peptide in treatment of osteoporosis [J]. Calcif Tissue Res, 1976,21 Suppl: 469-477.

同被引文献40

  • 1徐进,荣海钦,王东,刘春艳,季虹.人甲状旁腺激素相关蛋白片段对骨质疏松大鼠股骨和腰椎骨密度的影响[J].中国老年学杂志,2006,26(1):51-54. 被引量:2
  • 2肖扬,王万春.细胞因子与骨质疏松症[J].中国临床康复,2006,10(32):126-129. 被引量:12
  • 3Ivanova JI,Birnbaum HG,Schiller M. Real-world practice patterns,health-care utilization,and costs in patients with low back pain:the long road to guideline-concordant care[J].{H}SPINE JOURNAL,2011,(7):622-632.
  • 4Maniadakis N,Gray A. The economic burden of back pain in the UK[J].{H}PAIN,2000,(1):95-103.
  • 5Andersson GB. Epidemiology of low back pain[J].{H}Acta Orthopaedica Scandinavica Supplement,1998.28-31.
  • 6Manchikanti L,Boswell MV,Singh V. Comprehensive evidence-based guidelines for interventional techniques in the management of chronic spinal pain[J].Pain Physician,2009,(4):699-802.
  • 7Freburger JK,Holmes GM,Agans RP. The rising prevalence of chronic low back pain[J].{H}Archives of Internal Medicine,2009,(3):251-258.
  • 8Harrington EK,Roddy GW,West R. Parathyroid hormone/parathyroid hormone-related peptide modulates growth of avian sternal cartilage via chondrocytic proliferation[J].Anat Rec (Hoboken),2007,(2):155-167.
  • 9Borba VZ,Ma(n)as NC. The use of PTH in the treatment of osteoporosis[J].{H}Arquivos Brasileiros de Endocrinologia e Metabologia,2010,(2):213-219.
  • 10Adams SL,Cohen AJ,Lassová L. Integration of signaling pathways regulating chondrocyte differentiation during endochondral bone formation[J].{H}Journal of Cellular Physiology,2007,(3):635-641.

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部